Skip to main content

Crewe Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1730033 SALT LAKE CITY, UT

Position in GILD

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$130,382
+$21,535 QoQ
Shares Held
1,032
+32.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,964
of 2,266 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Crewe Advisors LLC holds $5,785,083 across 15 Drug Manufacturers - General names. GILD ranks #9 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $130,382 1,032
2026-03-31 $108,847 781
2025-12-31 $89,722 731
2025-09-30 $77,700 700
2025-06-30 $80,491 726
2025-03-31 $65,437 584
2024-12-31 $102,992 1,115
2024-09-30 $140,432 1,675
2024-06-30 $114,578 1,670
2024-03-31 $140,933 1,924
2023-06-30 $87,320 1,133
2023-03-31 $101,057 1,218
2022-12-31 $115,725 1,348
2022-09-30 $104,873 1,700
2022-06-30 $63,231 1,023
2022-03-31 $56,477 950
2021-12-31 $69,415 956
2020-09-30 $3,791 60